Metabonomics Analysis of Myocardial Metabolic Dysfunction in Patients with Cardiac Natriuretic Peptide Resistance

Table 1

Baseline characteristics of the study populations.

Variable	Health group (n = 30)	HF group (n = 30)	value
Age (years)	69.47 ± 4.97	71.17 ± 6.41	0.2557
Male (%)	16(53%)	17(57%)	−
Body mass index (kg/m^2)	23.64 ± 2.88	23.57 ± 2.58	0.9101
Biochemistry parameters
LDL (mg/dL)	2.11 ± 0.19	2.90 ± 0.15	<0.01
HDL (mg/dL)	1.63 ± 0.14	1.46 ± 0.12	<0.01
CHOL (mg/dL)	4.19 ± 0.13	4.81 ± 0.17	<0.01
TG (mg/dL)	1.40 ± 0.09	1.65 ± 0.11	<0.01

Clinical characteristics of all subjects. Values are expressed as the mean ± standard deviation, median (first quartile, third quartile), or %. HF: heart failure; BMI: body mass index; LVEF: left ventricular ejection fraction; LDL: low-density lipoprotein; HDL: high-density lipoprotein; CHOL: cholesterol; TG: triglycerides.